The document summarizes best practices for enhancing supply chain security in the pharmaceutical industry as described by the nonprofit Rx-360 consortium. It recommends that manufacturers: 1) perform in-depth supplier audits; 2) develop electronic records of raw material transactions; and 3) implement tamper-evident seals, advanced shipping notifications, and photographic libraries to track shipments. Following these practices can help manufacturers gain intimate knowledge of suppliers' operations and identify potential issues.
In this webinar, you will learn:
Sources of endotoxin contamination
Contamination control strategy
Endotoxin removal strategies
Detailed description:
Endotoxin, a lipopolysaccharide (LPS), is a type of pyrogen and is a component of the exterior cell wall of Gram-negative bacteria. To ensure safety on patient’s endotoxin content in the drug should always be controlled. In a biological processing it may emanate from facility, utility, raw materials, process, and personnel. In this webinar we discuss the regulatory norms, strategies for prevention & removal of endotoxin to ensure that the final drug product is safe.
Upstream Viral Safety: A Holistic Approach to Mitigating Contamination RisksMilliporeSigma
This whitepaper describes how different elements of viral safety can be integrated to minimize the risk of bioreactor contamination and the resulting disruption to biomanufacturing operations.
Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...MilliporeSigma
Register now to participate in the interactive, on-demand webinar: https://event.on24.com/wcc/r/3633644/850DBDCF39356D977DE6158F85BFAAC1?partnerref=SlideShare
In this webinar, you will learn:
- Different approaches for integrity testing single-use systems
- The benefits of the helium integrity test for increased integrity assurance in critical single-use systems
Detailed description:
Helium integrity testing is an industry-proven test that detects defects in single-use systems. This sensitive test reduces the risk of leaks or microbial ingress into manufacturing processes so manufacturers can be confident their entire systems, including tubing and connection points, are integral. This is especially critical during freezing, thawing, transportation and storage. This webinar will describe development and validation of the helium integrity test and demonstrate how it can benefit critical single-use process steps.
Quality by Design Principles Applied to Sterilizing Filtration by Michael PayneMilliporeSigma
Key regulatory documents and regulatory thinking now includes quality by design (QbD). This webinar focuses on how to integrate practical QbD activities into the process and analytical aspects of sterile medicinal product sterilizing filtration and qualification.
In this webinar, you will learn to:
• Focus on practical QbD terms and approaches
• Highlight critical product quality aspects of sterile medicinal products
• Develop design and control spaces for sterilizing filtration
• Easily integrate QbD into the process and analytical operations in early phase development and into manufacturing phase production
Abstract:
Final sterilizing filtration is the last operation in downstream processing to assure the sterility of medicinal products. Poorly defined product attributes process parameters may attract regulatory scrutiny, affect final product sterility and patient safety. A better understanding of QbD concepts and principles allows for better process and analytical monitoring and control at both early and final phase production. The webinar will show how currently available process cGMP information can be practically incorporated into QbD product quality attributes and process parameters. This is especially vital for the third party conducted laboratory work such as bacterial retention and leachable studies.
Welcome to the M Lab™ Collaboration Centers – where customers can use non-GMP lab spaces to operate equipment, evaluate processes and receive real-time technical support without disrupting production.
Plan your visit: www.merckmillipore.com/mlab
In this webinar, you will learn:
Sources of endotoxin contamination
Contamination control strategy
Endotoxin removal strategies
Detailed description:
Endotoxin, a lipopolysaccharide (LPS), is a type of pyrogen and is a component of the exterior cell wall of Gram-negative bacteria. To ensure safety on patient’s endotoxin content in the drug should always be controlled. In a biological processing it may emanate from facility, utility, raw materials, process, and personnel. In this webinar we discuss the regulatory norms, strategies for prevention & removal of endotoxin to ensure that the final drug product is safe.
Upstream Viral Safety: A Holistic Approach to Mitigating Contamination RisksMilliporeSigma
This whitepaper describes how different elements of viral safety can be integrated to minimize the risk of bioreactor contamination and the resulting disruption to biomanufacturing operations.
Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...MilliporeSigma
Register now to participate in the interactive, on-demand webinar: https://event.on24.com/wcc/r/3633644/850DBDCF39356D977DE6158F85BFAAC1?partnerref=SlideShare
In this webinar, you will learn:
- Different approaches for integrity testing single-use systems
- The benefits of the helium integrity test for increased integrity assurance in critical single-use systems
Detailed description:
Helium integrity testing is an industry-proven test that detects defects in single-use systems. This sensitive test reduces the risk of leaks or microbial ingress into manufacturing processes so manufacturers can be confident their entire systems, including tubing and connection points, are integral. This is especially critical during freezing, thawing, transportation and storage. This webinar will describe development and validation of the helium integrity test and demonstrate how it can benefit critical single-use process steps.
Quality by Design Principles Applied to Sterilizing Filtration by Michael PayneMilliporeSigma
Key regulatory documents and regulatory thinking now includes quality by design (QbD). This webinar focuses on how to integrate practical QbD activities into the process and analytical aspects of sterile medicinal product sterilizing filtration and qualification.
In this webinar, you will learn to:
• Focus on practical QbD terms and approaches
• Highlight critical product quality aspects of sterile medicinal products
• Develop design and control spaces for sterilizing filtration
• Easily integrate QbD into the process and analytical operations in early phase development and into manufacturing phase production
Abstract:
Final sterilizing filtration is the last operation in downstream processing to assure the sterility of medicinal products. Poorly defined product attributes process parameters may attract regulatory scrutiny, affect final product sterility and patient safety. A better understanding of QbD concepts and principles allows for better process and analytical monitoring and control at both early and final phase production. The webinar will show how currently available process cGMP information can be practically incorporated into QbD product quality attributes and process parameters. This is especially vital for the third party conducted laboratory work such as bacterial retention and leachable studies.
Welcome to the M Lab™ Collaboration Centers – where customers can use non-GMP lab spaces to operate equipment, evaluate processes and receive real-time technical support without disrupting production.
Plan your visit: www.merckmillipore.com/mlab
Pharma Serialization: Managing the TransformationCognizant
Serialization is a method for the pharmaceuticals industry to deter counterfeit drugs from being sold or given to medical patients; it follows precepts developed by PIE, EPCIS, and PIMMS. Implementing serialization internationally is a technical challenge for pharma, requiring coordination at every step of the products' lifecycle.
DSCSA and Blockchain, Global Governmental
perspective of Blockchain implementation in medtech Medtech
Possibilities
Information such as place of production
of active substances or component
parts, manufacturing locations, shipping
dates, batch numbers, expiry dates,
storage temperature and unique
identification numbers, could all be
stored and monitored on blockchain.
Although data standards are not new, they have become an increased priority because without them healthcare organizations experience substantial inaccuracies and inefficiencies in their data.
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceGreenlight Guru
Understand the FDA's new draft guidance on Computer Software Assurance (CSA).
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Fake Drugs? Not on Our Watch!
Worried about the safety of your medications? This blog post dives deep into the world of pharmaceutical traceability software, the guardian angel of patient safety. Discover how this innovative technology combats counterfeit drugs, optimizes supply chains, and fosters regulatory compliance. Explore the exciting possibilities of blockchain, RFID, and barcoding, revolutionizing real-time tracking and verification in pharmaceuticals
Biometrics Provide Strategic Business Advantage in Pharmaceutical ManufacturingARC Advisory Group
Biometrics Provide Strategic Business Advantage in Pharmaceutical Manufacturing
The pharmaceutical industry is faced with increasing regulatory requirements
to provide work flow enforcement and event traceability as well as
to ensure the integrity, authenticity, and confidentiality
of electronic records. This requires physical
and logical security that includes policies, procedures
and technology. Consequently,
pharmaceutical manufacturers will be the first to
deploy biometric technology. Biometrics-based
access, authentication, electronic signature, and
event traceability systems also reduce the cost and time to achieve and
maintain compliance with current and future FDA regulations, protect intellectual
property, improve manufacturing productivity and safety, and
reduce system administration costs.
This brief .PDF explains a bit more about our Ingredient SAFE solution, and how it was applied to Golden State Foods - one of the largest diversified suppliers to the foodservice industry, servicing more than 20,000 restaurants from three continents.
Recipe for successful Supply Chain Risk ManagementHeiko Schwarz
This white paper serves as support for everyone involved in implementing supply chain risk management (SCRM). These guidelines are intended to provide companies with a checklist containing all the ingredients that are important for setting up professional, successful supply chain risk management. In this way, time-consuming delays and costly errors can be avoided. The individual chapters contain detailed descriptions on the following ingredients for a comprehensive supply chain risk management process, and how to integrate them in an organization:
- Definition of the scope
- Definition of risks to be monitored ("Risk Inventory")
- Supply chain transparency
- Risk identification
- Risk assessment
- Action plan management for minimizing risks
- Integration into further procurement processes
As the approach described in this white paper is a generic one, specifics must be adapted to the relevant sector and company size in order to adapt the generic concept accordingly . You can find a detailed description of the benefits and the return on investment of supply chain risk management in the "ROI of Supply Chain Risk Management" study .
As is the case with any dish: Adjust the ingredients according to your personal (company-specific) liking!
More Related Content
Similar to White paper rx-360 - all-around security for pharmaceutical supply chains (pdf] (1)
Pharma Serialization: Managing the TransformationCognizant
Serialization is a method for the pharmaceuticals industry to deter counterfeit drugs from being sold or given to medical patients; it follows precepts developed by PIE, EPCIS, and PIMMS. Implementing serialization internationally is a technical challenge for pharma, requiring coordination at every step of the products' lifecycle.
DSCSA and Blockchain, Global Governmental
perspective of Blockchain implementation in medtech Medtech
Possibilities
Information such as place of production
of active substances or component
parts, manufacturing locations, shipping
dates, batch numbers, expiry dates,
storage temperature and unique
identification numbers, could all be
stored and monitored on blockchain.
Although data standards are not new, they have become an increased priority because without them healthcare organizations experience substantial inaccuracies and inefficiencies in their data.
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceGreenlight Guru
Understand the FDA's new draft guidance on Computer Software Assurance (CSA).
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Fake Drugs? Not on Our Watch!
Worried about the safety of your medications? This blog post dives deep into the world of pharmaceutical traceability software, the guardian angel of patient safety. Discover how this innovative technology combats counterfeit drugs, optimizes supply chains, and fosters regulatory compliance. Explore the exciting possibilities of blockchain, RFID, and barcoding, revolutionizing real-time tracking and verification in pharmaceuticals
Biometrics Provide Strategic Business Advantage in Pharmaceutical ManufacturingARC Advisory Group
Biometrics Provide Strategic Business Advantage in Pharmaceutical Manufacturing
The pharmaceutical industry is faced with increasing regulatory requirements
to provide work flow enforcement and event traceability as well as
to ensure the integrity, authenticity, and confidentiality
of electronic records. This requires physical
and logical security that includes policies, procedures
and technology. Consequently,
pharmaceutical manufacturers will be the first to
deploy biometric technology. Biometrics-based
access, authentication, electronic signature, and
event traceability systems also reduce the cost and time to achieve and
maintain compliance with current and future FDA regulations, protect intellectual
property, improve manufacturing productivity and safety, and
reduce system administration costs.
This brief .PDF explains a bit more about our Ingredient SAFE solution, and how it was applied to Golden State Foods - one of the largest diversified suppliers to the foodservice industry, servicing more than 20,000 restaurants from three continents.
Recipe for successful Supply Chain Risk ManagementHeiko Schwarz
This white paper serves as support for everyone involved in implementing supply chain risk management (SCRM). These guidelines are intended to provide companies with a checklist containing all the ingredients that are important for setting up professional, successful supply chain risk management. In this way, time-consuming delays and costly errors can be avoided. The individual chapters contain detailed descriptions on the following ingredients for a comprehensive supply chain risk management process, and how to integrate them in an organization:
- Definition of the scope
- Definition of risks to be monitored ("Risk Inventory")
- Supply chain transparency
- Risk identification
- Risk assessment
- Action plan management for minimizing risks
- Integration into further procurement processes
As the approach described in this white paper is a generic one, specifics must be adapted to the relevant sector and company size in order to adapt the generic concept accordingly . You can find a detailed description of the benefits and the return on investment of supply chain risk management in the "ROI of Supply Chain Risk Management" study .
As is the case with any dish: Adjust the ingredients according to your personal (company-specific) liking!
Similar to White paper rx-360 - all-around security for pharmaceutical supply chains (pdf] (1) (20)
Recipe for successful Supply Chain Risk Management
White paper rx-360 - all-around security for pharmaceutical supply chains (pdf] (1)
1. TM
PERFORMANCE MATERIALS
WhitePaper
Rx-360: All-Around Security for
Pharmaceutical Supply Chains
BY: Joe Woodward
Global Director of Planning and Logistics,
Avantor™ Performance Materials
Introduction Purpose
“The tragedies related to economically motivated The purpose of this white paper is to describe Best
adulteration of glycerin in Haiti, Panama, and Nigeria, as Practices that can be implemented by manufacturers to
well as heparin used in the United States and Europe, and enhance global supply chain security. These Best Practices
melamine found in various products throughout the world, represent those implemented by members of Rx-360, a
have taught us that unethical individuals and criminals nonprofit consortium recently developed by volunteers
have entered the pharmaceutical supply chain with tragic from the pharmaceutical and biotech industries, including
consequences,” said Martin Van Trieste, founding chair manufacturers and their suppliers. The Rx-360 mission is
of Rx-360.1 to enhance supply chain security and ensure the quality
and authenticity of the materials moving through the
Recent tragic events involving adulterated pharmaceutical
supply chain.3 The organization works to enhance security
and food products have focused the attention of
and patient safety by auditing member organizations
pharmaceutical manufacturers, as well as the U.S. Food
that supply materials to the pharmaceutical supply chain.
and Drug Administration, on supply chain processes.2 The
Rx-360 then provides supplier audits to the organization’s
pharmaceutical industry is also increasing its focus on
pharmaceutical manufacturing members to facilitate
supply chain security because of concerns about deliberate
information sharing. Keep in mind that although Rx-360 can
tampering, counterfeiting, and theft, in addition to
provide manufacturers with valuable information, it is still
contamination.2 Criminal enterprises have made counterfeit
the responsibility of each Rx-360 company to make its own
drugs and the theft of pharmaceutical chemicals into
decision about suppliers, based on its own company product
lucrative sources of illicit gain. Industry members are
requirements, policies, and procedures.2
responding to these concerns by improving and increasing
the level of cross-company collaboration, as well as by
General
implementing company-specific initiatives.
A secure supply chain leads to open communication,
The best way to enhance supply chain security is for
problem prevention, constructive feedback and increased
manufacturers to have intimate knowledge of materials
product safety—all of which results in consistent and reliable
suppliers and their methods of manufacturing, storing,
products that can promote health and improve patient lives.
and transporting the materials. However, obtaining
this information can be quite resource-intensive and Enhancing the safety and reliability of the pharmaceutical
challenging for individual companies. Collaborative ventures supply chain has become a critical component of
between pharmaceutical manufacturers to safeguard manufacturing operations in an increasingly complex
today’s extensive global supply chains are becoming more sourcing environment, with more at stake than ever.
attractive to companies. Suppliers are the critical link in the supply chain that
W H I T E P A P E R | www.avantormaterials.com
2. ultimately delivers value to the consumer, along with safe and These details can then be checked against the actual
effective products for clinicians and patients. Manufacturers shipment for irregularities that could be evidence of
should always collaborate with suppliers to enhance supply tampering, theft, or contamination.
chain security.4 5. Assemble photographic libraries of product labels, seals,
The Rx-360 consortium supports a number of Best Practices watermarks, etc., for accurate records of raw material
that help manufacturers enhance supply chain security. shipments. Incoming materials can then be checked
against the photographic library to ensure accuracy.
Supply Chain Security Best Practices3,4,5,6 Photographic representation of all products can help
inspectors/auditors recognize exactly what to look for
1. Perform in-depth audits that identify carrier/shipping and what types of tamper-evident seals are being used
procedures and practices (based on thorough checklists, with each product packaging.
including evaluation of documentation systems), as well
6. Perform right-size testing to match the stringency of
as manufacturing processes and details concerning the
the materials test (e.g., mass spectrometry/GC) and
supplier’s facilities.
the need for specialized training and instrumentation
2. Work with suppliers to develop an “e-pedigree” for with the perceived level of risk. For some products, it
all materials, in the form of an electronic record of may be appropriate to streamline testing procedures to
each transaction that results in a change of ownership obtain greater throughput and cost-effectiveness. For
of a given raw material. This includes all transitions/ others, sophisticated and specialized techniques, such
transportation between owners or handling locations. as nuclear magnetic resonance (NMR) imaging, may
While this is a complex task, the necessary technology be required. Additionally, suppliers and manufacturers
itself (information systems, authentication methods, should ensure categorization alignment—or a clear
automation, RFID scanning, bar code encoding, etc.) is understanding of product grades, specifications and
mature and available. But the technology has not yet regulatory requirements—not only to ensure right-size
been employed as the basis for solutions that encompass testing, but also to secure the proper grade selection for
the entire supply chain back to the raw materials level. a product’s purpose.
Some suppliers are currently working on solutions that,
7. Explore new technological options such as FedEx’s
once identified, all suppliers should consider enacting.
in-flight, real-time GPS-based monitoring of shipments
Additionally, a comprehensive e-pedigree system would
and FreightWatch’s tracking and alarm systems to
require unique item identification or serialization of each
signal possible theft or hijacking. Technologies such as
product for easier tracking. Suppliers and manufacturers
RFID should be integrated with an overall database for
must work together to track raw materials through the
globally accessible tracking data.
supply chain.
All of these items should be built into an integrated quality
3. Require tamper-evident seals that are uniquely
system featuring consistent, well-developed procedures that
identifiable (e.g., with supplier logo and/or name), multi-
are sustainable over time and across the complete variety of
layer (e.g., both outer container seals and individual
materials being shipped and received.
product seals inside), and globally standardized. The
customer should be prepared to review and inspect the These practices can be highly effective in risk management
seals every time product is received. and maximizing security. However, they require teamwork
4. Obtain advanced shipping notification of all details and close cooperation along each link in the supply chain, so
regarding every shipment (e.g., vendor/distributor name that manufacturers have a solid understanding of everything
and part number, ship date, shipment number, quantity, that goes into their products.
PRO/bill of lading, lot number, and expiration date).
W H I T E P A P E R | www.avantormaterials.com | 2